Remission Evaluation of a Metabolic Intervention in Type 2 Diabetes With Forxiga
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 27 Sep 2017
At a glance
- Drugs Dapagliflozin (Primary) ; Insulin glargine; Metformin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 18 Sep 2017 Planned End Date changed from 1 Mar 2018 to 1 Oct 2018.
- 18 Sep 2017 Status changed from recruiting to active, no longer recruiting.
- 10 Jun 2017 Biomarkers information updated